Prudential Financial
HUMA icon

Prudential Financial’s Humacyte HUMA Stock Holding History

Prudential Financial’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,165
Closed -$13.4K – 2534
2026
Q1 		$13.4K Buy
+22,165
New +$23K ﹤0.01% 2390
2025
Q4 		– Sell
-13,320
Closed -$23.2K – 2313
2025
Q3 		$23.2K Buy
13,320
+155
+1% +$304 ﹤0.01% 2393
2025
Q2 		$27.5K Buy
+13,165
New +$25.3K ﹤0.01% 2384
2024
Q3 		– Sell
-157,305
Closed -$755K – 2746
2024
Q2 		$755K Buy
+157,305
New +$819K ﹤0.01% 1987

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Prudential Financial's HUMA Position: Q2 2026 in Review

Prudential Financial sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 22,165 shares — an estimated $13.4K sold.

Prudential Financial first reported a position in HUMA in Q2 2024 and held it in 4 quarters. The position peaked at $755K in Q2 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Prudential Financial reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Prudential Financial sold 22,165 Humacyte shares in Q2 2026, an estimated $13.4K.
  • Prudential Financial first reported a position in Humacyte in Q2 2024 and held it in 4 quarters.
  • Prudential Financial's Humacyte position peaked at $755K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.